Active, Not Recruiting
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)
NCT03157128
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Any Solid Tumor, +46 more
- Locations
-
- Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical Center Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States